Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:48 PM
Ignite Modification Date:
2025-12-24 @ 7:48 PM
NCT ID:
NCT02799303
Eligibility Criteria:
Inclusion Criteria:
* age greater than or equal to 50 years old
* life expectancy greater than or equal to 10 years, according to the clinical judgement of study investigators
Exclusion Criteria:
* history of previous prostate biopsy
* PSA level measurement within 3 years of recruitment date
* abnormal digital rectal examination of the prostate consistent with prostate cancer
* history of prostate cancer in one or more first-degree relatives diagnosed at less than 50 years of age
* lower urinary tract voiding symptoms (IPSS greater than or equal to 8)
* prior or current use of 5-alpha reductase inhibitor medications (finasteride or dutasteride)
* patient unable to communicate in English in order to give proper informed consent
* claustrophobia or other medical indication which would preclude MRI
* any medical condition which, in the opinion of the investigator, might interfere with the evaluation of the study objectives
Healthy Volunteers:
True
Sex:
MALE
Minimum Age:
50 Years
Study:
NCT02799303
Study Brief:
Protocol Section:
NCT02799303